Yuyu Pharma (A000220) Stock Overview
Develops and markets pharmaceutical products. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
A000220 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Yuyu Pharma, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩4,130.00 |
| 52 Week High | ₩5,100.00 |
| 52 Week Low | ₩3,900.00 |
| Beta | 0.32 |
| 1 Month Change | -4.18% |
| 3 Month Change | -6.88% |
| 1 Year Change | -1.31% |
| 3 Year Change | -33.39% |
| 5 Year Change | -41.63% |
| Change since IPO | 388.96% |
Recent News & Updates
Yuyu Pharma (KRX:000220) Has Announced A Dividend Of ₩100.00
Nov 09
We Think Yuyu Pharma's (KRX:000220) Solid Earnings Are Understated
May 23Recent updates
Yuyu Pharma (KRX:000220) Has Announced A Dividend Of ₩100.00
Nov 09We Think Yuyu Pharma's (KRX:000220) Solid Earnings Are Understated
May 23Yuyu Pharma, Inc.'s (KRX:000220) 25% Share Price Surge Not Quite Adding Up
Jan 08Unpleasant Surprises Could Be In Store For Yuyu Pharma, Inc.'s (KRX:000220) Shares
Nov 13Concerns Surrounding Yuyu Pharma's (KRX:000220) Performance
Aug 24Pinning Down Yuyu Pharma, Inc.'s (KRX:000220) P/S Is Difficult Right Now
Aug 07Here's Why Yuyu Pharma (KRX:000220) Has A Meaningful Debt Burden
Apr 02Should Yuyu Pharma, Inc. (KRX:000220) Be Part Of Your Dividend Portfolio?
Mar 08The Yuyu Pharma (KRX:000220) Share Price Has Gained 12% And Shareholders Are Hoping For More
Feb 10
We Wouldn't Rely On Yuyu Pharma's (KRX:000220) Statutory Earnings As A Guide
Jan 07Yuyu Pharma (KRX:000220) Seems To Use Debt Quite Sensibly
Dec 20Would Yuyu Pharma, Inc. (KRX:000220) Be Valuable To Income Investors?
Dec 03Shareholder Returns
| A000220 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 1.0% | 0.2% | -3.8% |
| 1Y | -1.3% | 10.4% | 49.7% |
Return vs Industry: A000220 underperformed the KR Pharmaceuticals industry which returned 10.4% over the past year.
Return vs Market: A000220 underperformed the KR Market which returned 49.7% over the past year.
Price Volatility
| A000220 volatility | |
|---|---|
| A000220 Average Weekly Movement | 1.9% |
| Pharmaceuticals Industry Average Movement | 4.0% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in KR Market | 10.7% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A000220 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A000220's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1941 | 254 | Robert Yu | www.yuyu.co.kr |
Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Jecheon-si, South Korea.
Yuyu Pharma, Inc. Fundamentals Summary
| A000220 fundamental statistics | |
|---|---|
| Market cap | ₩65.26b |
| Earnings (TTM) | ₩3.95b |
| Revenue (TTM) | ₩135.32b |
Is A000220 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A000220 income statement (TTM) | |
|---|---|
| Revenue | ₩135.32b |
| Cost of Revenue | ₩83.86b |
| Gross Profit | ₩51.45b |
| Other Expenses | ₩47.50b |
| Earnings | ₩3.95b |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 250.55 |
| Gross Margin | 38.02% |
| Net Profit Margin | 2.92% |
| Debt/Equity Ratio | 20.7% |
How did A000220 perform over the long term?
See historical performance and comparisonDividends
Does A000220 pay a reliable dividends?
See A000220 dividend history and benchmarks| Yuyu Pharma dividend dates | |
|---|---|
| Ex Dividend Date | Dec 29 2025 |
| Dividend Pay Date | Apr 16 2026 |
| Days until Ex dividend | 49 days |
| Days until Dividend pay date | 157 days |
Does A000220 pay a reliable dividends?
See A000220 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/10 08:35 |
| End of Day Share Price | 2025/11/10 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Yuyu Pharma, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.